FIELD: medicine. SUBSTANCE: method involves administering preparations of antioxidation activity like alpha-tocopherol and trimetazidine during 10-14 days before beginning hyperbaric oxygenation treatment. EFFECT: avoided excessive lipid peroxidation; reduced risk of complications.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING HYPERBARIC OXYGENATION TREATMENT EFFECTIVENESS | 2000 |
|
RU2192836C2 |
METHOD FOR ADJUSTING HEMORHEOLOGIC DISORDERS IN CARDIAC ISCHEMIA PATIENTS | 2004 |
|
RU2292861C2 |
METHOD FOR CONTROLLING THE SAFETY OF HYPERBARIC OXYGENATION PROCEDURE | 2002 |
|
RU2218141C1 |
METHOD FOR CONTROL OF THERAPEUTIC EFFICIENCY AT ISCHEMIC CARDIAC DISEASE | 2001 |
|
RU2199264C2 |
METHOD OF CORONARY DISEASE TREATMENT | 2007 |
|
RU2349297C1 |
METHOD FOR PREVENTING THROMBOGENESIS AT CARRYING OUT CORONARY ANGIOPLASTY AND STENTING | 2004 |
|
RU2294746C2 |
METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2428978C1 |
METHOD FOR REHABILITATION IN PATIENTS AT ISCHEMIC CARDIAC DISEASE AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | 2006 |
|
RU2322237C1 |
METHOD OF CORONARY DISEASE TREATMENT | 2006 |
|
RU2349296C2 |
Authors
Dates
2002-11-20—Published
2001-01-09—Filed